Mushrooms MSRM · USD

Its shares trade under the ticker MSRM. It has been listed since 17 November 2006. In the fiscal year to 31 December 2025, it reported revenue of $2,384 and a net loss of $25,216. At that date it held total assets of $12,972 and shareholders' equity of −$64,062.

Mushrooms, Inc. is a development stage company, which acquires and builds a portfolio of cannabis markets. The company is headquartered in Estero, Florida. The company went IPO on 2006-11-17. The Company’s research and development is focused on bringing the science of mycology to the forefront of manufacturing by replacing toxic plastics, packaging, and improving medical threads and fabrics. Mycelium is a natural fiber, which is used as an alternative to plastics. The mycelium can be used in applications such as insulation, structural insulating panels, acoustical tiles, and building blocks. The company is improving the threads and fabrics in use with its antimicrobial, anti-MRSA, renewable and eco-positive threads and fabric solutions. The company also works together with scientists and medical supply innovators to implement this technology into the range of potential medical applications.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Phillip MalkemesPresident, Director, since 2017
• Mr. Patrick MontalbanChief Executive Officer, Director, since 2002
• Danny MitchellVice President, Corporate Secretary, Director, since 2002
• Bruce HirscheDirector
• Mr. Arman TabatabaeiIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.